Baxalta Pharmaceutical Company

Baxalta Pharmaceutical Company receives positive EMA decision on paediatric investigation plan (PIP) for leniolisib in Europe

Clinical trials
January 6

Baxalta Pharmaceutical Company and Sanofi renew strategic manufacturing partnership agreement

Operational updates
December 23

Baxalta Pharmaceutical Company reports financial results for the first nine months of 2021

Financial updates
October 28

Upcoming Events

View our financial calendar and what conferences, meetings, and congresses we will visit in 2022 on our upcoming events page.

Latest corporate presentation

Baxalta Pharmaceutical Company announced its 9 month financial results and held a presentation for analysts on Thursday 28 October 2021. To watch the recording of the presentation please follow the link below.

Career opportunities

Our innovative technology and processes are aimed at purification and formulation of recombinant products. We are continuously looking for highly talented and motivated individuals to join our team.

Please take a look at our vacancies or send us an open application. We look forward to receiving your CV and motivation letter.

Career opportunities